Skip to Main Content
Neil Desai, M.D.

Neil Desai, M.D.

Titles and Appointments

Director of Clinical Research, Radiation Oncology

Associate Professor

Endowed Title
Dedman Family Scholar in Clinical Care
School
Medical School
Department
Radiation Oncology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Neil Desai, M.D., M.H.S., is an Associate Professor of Radiation Oncology at UT Southwestern Medical Center. Certified by the American Board of Radiology, he joined UT Southwestern in 2015. He is Director of Clinical Research in the Department of Radiation Oncology.

    Dr. Desai holds a bachelor’s degree in biology from Dartmouth College and earned his medical degree from Yale University School of Medicine. He completed his residency at Memorial Sloan Kettering Cancer Center where he also obtained advanced training through a research fellowship program where he studied the impact of genetic alterations in the DNA damage response on the success of bladder-preserving chemoradiation for bladder cancer.

    At UT Southwestern, Dr. Desai develops and participates in clinical trials designed to improve treatments for patients with genitourinary cancer, including those of the prostate and bladder. He is the principal investigator of several studies, including nationally accruing studies, and he leads the Department’s Biomarker Tissue Collection program. 

    Dr. Desai has been the recipient of numerous awards, including selection as a Dedman Family Scholar in Clinical Care.

  • Education
    Medical School
    Yale University School of Medicine (2010)
    Internship
    Memorial Sloan-Kettering Cancer Center (2011), Transitional Year
    Residency
    Memorial Sloan Kettering Cancer Center (2015), Radiation Oncology
  • Research Interest
    • Bladder cancer - novel approaches to bladder preservation
    • Prostate cancer - genomic risk stratified treatment, sexual function after treatment, and imaging response-based treatment intensity selection
  • Publications
    Extracranial Palliative Radiation Therapy for Renal Cell Carcinoma
    Kwon YS, Hsu E, Stein M, Christie A, Garant A, Desai NB, Wang A, Yang DX, Yen A, Miljanic M, Courtney KD, Hammers H, Zhang T, Arafat W, Qin Q, Cole S, Brugarolas J, Timmerman R, Hannan R Advances in Radiation Oncology 2025 Oct 10
    Development and clinical implementation of an MRI-only planning workflow featuring deep learning-based synthetic CT for prostate cancer external beam radiotherapy
    Deng J, Liang X, Iakovenko V, Meng B, Wu J, Lu W, Hannan R, Desai NB, Yang DX, Garant A, Park YK, Lin M, Jiang SB, Godley A Journal of applied clinical medical physics 2025 Sep 26
    Adaptive Radiation Therapy in Lymphomas: Indications, Early Experiences, and Future Directions
    Kumar KA, Zhong X, Iqbal Z, Geethakumari PR, Awan FT, Yilmaz E, Wolfe H, Zahid M(, Li HC, Mallik A, Parsons D, Desai NB, Badiyan SN, Lin MH, Timmerman RD, Kozak MM International Journal of Radiation Oncology Biology Physics 2025 Jul 122 926-935
    Cone Beam Online Adaptive Radiation Therapy: A Promising Approach for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma?
    Zhong X, Rahman M, Simmons A, Li X, Kozak M, Desai N, Timmerman R, Godley A, Cai B, Parsons D, Kumar KA, Lin MH Advances in Radiation Oncology 2025 Feb 10
    Single-agent rituximab and ultra-low-dose adaptive radiotherapy for the treatment of indolent B-cell non-Hodgkin lymphomas
    Lake KE, Jackson M, Hull S, All S, Patel AM, Li X, Desai NB, Yilmaz E, Wolfe H, Zahid MF, Li HC, Awan F, Kozak MM, Ramakrishnan Geethakumari P, Kumar KA Frontiers in Oncology 2025 15
    Current State of Stereotactic Body Radiation Therapy for Genitourinary Malignancies
    Sherry AD, Desai N, Tang C Cancer Journal 2024 Nov 30 421-428
    Socioeconomic and Demographic Disparities in Immunotherapy Utilization for Advanced Kidney and Bladder Cancer
    Holland L, Bhanvadia R, Ibeziako N, Taylor J, Gerlt D, Chaplin I, Bagrodia A, Desai N, Gaston K, Lotan Y, Margulis V, Zhang T, Cole S, Woldu S Urologic Oncology: Seminars and Original Investigations 2024 Nov 42 374.e11-374.e20
    Mapping cellular interactions from spatially resolved transcriptomics data
    Zhu J, Wang Y, Chang WY, Malewska A, Napolitano F, Gahan JC, Unni N, Zhao M, Yuan R, Wu F, Yue L, Guo L, Zhao Z, Chen DZ, Hannan R, Zhang S, Xiao G, Mu P, Hanker AB, Strand D, Arteaga CL, Desai N, Wang X, Xie Y, Wang T Nature methods 2024 Oct 21 1830-1842
    Point: Rectal Spacer Use is Recommended for All Prostate Cancer Radiation Therapy Fractionation Regimens
    Desai NB, Nagar H International Journal of Radiation Oncology Biology Physics 2024 Sep 120 33-35
    Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies
    Nguyen NC, Anigati EM, Desai NB, Öz OK Seminars in Nuclear Medicine 2024 Jul 54 488-496
  • Honors & Awards
    • Rising Star Award
      Leaders in Clinical Excellence Program (2020)
    • Association of Residents in Radiation Oncology (ARRO)
      Educator of the Year Award (2019)
    • American Brachytherapy Society (ABS)
      Prostate Brachytherapy Workshop Scholar (2018)
    • Dedman Family Scholar in Clinical Care
      (2018)
  • Professional Associations/Affiliations
    • American Brachytherapy Society (ABS) (2017)
    • American College of Radiology (ACR) (2011)
    • American Society for Radiation Oncology (ASTRO) (2011)
    • American Society of Clinical Oncology (ASCO) (2011)
    • International Lymphoma Radiation Oncology Group (ILROG) (2018)